GLP-1 receptor agonists, such as Ozempic and Mounjaro, are a class of medications that work by mimicking the natural GLP-1 hormone and support weight loss by slowing down stomach emptying and lowering blood sugar levels
Similar concerns have been seen with lipid outcomes with an increase in total cholesterol after cessation of semaglutide to near pretreatment levels and loss of around two-thirds of the benefit in triglycerides, while positive changes in LDL-C and HDL-C were more modest but appeared more durable (Table 2) [73]
Temporary soreness during rapid weight loss is a metabolic adaptation, not tissue damage, and resolves once hydration and protein intake improve
The hierarchy dictates that chemotherapy codes always take absolute precedence over standard therapeutic infusion codes
Nausea, vomiting, and diarrhea are common, and depending on the person there are real risks of acute kidney injury, gallstones, and pancreatitis, plus muscle and bone loss in older adults
Research on B
